Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Velenik, Vaneja ^a   Oblak, Irena ^a   Anderluh, Franc ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DERMATITIS; DISEASE SEVERITY; FOLLOW UP; HUMAN; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEOADJUVANT THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PREOPERATIVE CHEMOTHERAPY; PREOPERATIVE RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CARCINOMA; RECTUM SURGERY; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; ABDOMINAL SURGERY; ADENOCARCINOMA; ADJUVANT THERAPY; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MORTALITY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR; TIME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECTAL NEOPLASMS; TIME;

EID: 77957128188     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717x-5-88     Document Type: Article

References (41)

1. Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M: Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000, 284:1008-1015
2. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001, 358:1291-1304
3. Gagel B, Piroth M, Pinkawa M, Pinkawa M, Reinartz P, Zimny M, Fischedik K, Stanzel S, Breuer C, Skobel E, Asadpour B, Schmachtenberg A, Buell U, Eble MJ: Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer. A phase I study. Strahlenther Onkol 2006, 182:263-269
4. Kortmann B, Reimer T, Gerber B, Klautke G, Fietkau R: Concurrent radiochemotherapy of locally recurrent or advanced sarcomas of the uterus. Strahlenther Onkol 2006, 182:318-324
5. Rades D, Schulte R, Yekebas EF, Homann N, Schild SE, Dunst J: Radio (chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer. Strahlenther Onkol 2007, 183:10-16
6. Semrau S, Gerber B, Reimer T, Klautke G, Fietkau R: Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. Strahlenther Onkol 2006, 182:596-603
7. Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol 2005, 23:5620-5627
8. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, EORTC Radiotherapy Group Trial 22921: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123
9. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625
10. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740
11. Bajetta E, Beretta E, Di Bartolomeo M, Mariani L, Valvo F, Ferrario E, Mancin M, Dognini G, Buzzoni R: Capecitabine chemoradiation for rectal cancer after curative surgery. J Chemother 2006, 18:85-89
12. Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, Bugat R, Burger U, Garin A, Graeven U, McKendric J, Maroun J, Marshall J, Osterwalder B, Pérez-Manga G, Rosso R, Rougier P, Schilsky RL, Capecitabine Colorectal Cancer Study Group: First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002, 13:566-575
13. Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kröning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schüller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W: Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005, 352:2696-2704
14. Van Cutsem E, Findlay M, Osterwalder B, Kocha W, Dalley D, Pazdur R, Cassidy J, Dirix L, Twelves C, Allman D, Seitz JF, Schölmerich J, Burger HU, Verweij J: Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol 2000, 18:1337-1345
15. Van Cutsem E, Hoff PM, Harper P, Bukowski RM, Cunningham D, Dufour P, Graeven U, Lokich J, Madajewicz S, Maroun JA, Marshall JL, Mitchell EP, Perez-Manga G, Rougier P, Schmiegel W, Schoelmerich J, Sobrero A, Schilsky RL: Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomized, phase III trials. Br J Cancer 2004, 90:1190-1197
16. Glynne-Jones R, Dunst J, Sebag-Montefiore D: The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Ann Oncol 2006, 17:361-371
17. Saif MW, Hashmi S, Zelterman D, Almhanna K, Kim R: Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis 2008, 23:139-145
18. Kim DY, Jung KH, Kim TH, Kim DW, Chang HJ, Jeong JY, Kim YH, Son SH, Yun T, Hong CW, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG: Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007, 67:378-384
19. Velenik V, Anderlih F, Oblak I, Strojan P, Zakotnik B: Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced respectable rectal cancer: prospective phase II trial. Croat Med J 2006, 47:693-700
20. National Comprehensive Cancer Network: National Comprehensive Cancer Network clinical practice guidelines, Rectal cancer.[http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#site]
21. LENT SOMA tables: Radiother Oncol 1995, 35:17-60
22. Velenik V, Anderluh F, Oblak I, Strojan P, Segedin B, Zakotnik B: Preoperative capecitabine and concomitant radiotherapy in operable rectal cancer: a phase II study with 2 years follow-up. Science and multidisciplinary management of GI malignancies: Proceedings book Alexandria, VA: American Society of Clinical Oncology 2008, 325
23. Dunst J, Debus J, Rudat V, Wulf J, Budach W, Hoelscher T, Reese T, Mose S, Roedel C, Zuehlke H, Hinke A: Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer. Strahlenther Onkol 2008, 184:450-456
24. Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D: Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer 2007, 97:1333-1337
25. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor risk rectal cancer. J Clin Oncol 2006, 24:668-674
26. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, Pasetto L, Santantonio M, Sarti E, Mantello G, Innocente R, Frustaci S, Corvò R, Rosso R: Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable rectal cancer: a multicentric phase II study. Ann Oncol 2006, 17:246-251
27. Desai SP, El-Rayes BF, Ben-Josef E, Greenson JK, Knol JA, Huang EH, Griffith KA, Philip PA, McGinn CJ, Zalupski MM: A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer. Am J Clin Oncol 2007, 30:340-345
28. Dunst J, Reese T, Sutter T, Zühlke H, Hinke A, Kölling-Schlebusch K, Frings S: Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002, 20:3983-3991
29. Dupuis O, Vie B, Liedo G, Hennequin C, Noirclerc M, Bennamoun M, Jacob JH: Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR phase II study. Oncology 2007, 73:169-176
30. Freedman GM, Meropol NJ, Sigurdson ER, Hoffman J, Callahan E, Price R, Cheng J, Cohen S, Lewis N, Watkins-Bruner D, Rogatko A, Konski A: Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007, 67:1389-1393
31. Kim JS, Kim JS, Cho MJ, Song KS, Yoon WH: Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002, 54:403-408
32. Kocakova I, Svoboda M, Klocova K, Chrenko V, Roubalova E, Krejci E, Sefr R, Slampa P, Frgala T, Zaloudik J: Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy. Proc Am Soc Clin Oncol 2004, 23:299 abstract 3720
33. Korkolis DP, Boskos CS, Plataniotis GD, Gontikakis E, Karaitianos IJ, Avgerinos K, Katopodi A, Xinopoulos D, Dimitroulopoulos D, Beroukas K, Vassilopoulos PP: Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. Anticancer Res 2007, 27:541-545
34. Lay GC, Caraul B, Dessi M, Orrù S, Murtas R, Deidda MA, Farigu R, Farci D, Maxia L, Casula G, Amichetti M: Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma. J Exp Clin Cancer Res 2007, 26:61-70
35. Lin EH, Skibber J, Delcos M: A phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients with locally advanced rectal cancer. J Clin Oncol 2005, 23(Suppl 16):269s, abstract 3593
36. Ngan SY, Michael M, Mackay J, McKendrick J, Leong T, Lim Joon D, Zalcberg JR: A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer 2004, 91:1019-1024
37. Shen W, Liu Y, Ma X: Capecitabine combined with radiotherapy in Chinese patients with advanced or relapsed rectal carcinoma. Proc Am Soc Clin Oncol 2004, 23:287 abstract 3671
38. Veerasarn V, Phromratanapongse P, Lorvidhava V, Lertsanguansinchai P, Lertbutsayanukul C, Panichevaluk A, Boonnuch W, Chinswangwatanakul V, Lohsiriwat D, Rojanasakul A, Thavichaigarn P, Jivapaisarnpong P: Preoperative capacitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). J Med Assoc Thai 2006, 89:1874-1884
39. Wong SJ, Sadasiwan C, Erickson B: A phase I trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer. Proc Am Soc Clin Oncol 2004, 23:312 abstract 3771
40. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM: Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2005, 63:346-353
41. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH: Preoperative chemoradiation with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 2006, 66:1378-1383